Everfront Biotech Holding Company Limited (EFB)

Chart not available yet

Data will show when the stock starts trading.

Market Cap	n/a
Revenue (ttm)	n/a
Net Income (ttm)	-2.13M
Shares Out	n/a
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About EFB

Everfront Biotech IS a clinical stage biopharmaceutical company dedicated to the discovery, development and commercialization of new drugs that have potential as treatments for patients with cancers, neurodegenerative diseases and rare diseases. We are conducting three clinical trials in Taiwan under the approval of the United States Food and Drug Administration and the Taiwan Food and Drug Administration. As of the date of this prospectus, we have no products approved for commercial sale and have never generated any revenue from product sales.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2010
• Employees: 14
• Stock Exchange: NASDAQ
• Ticker Symbol: EFB
• Website: https://www.efbiotech.com/

Financial Performance

Financial numbers in USD